Xenetic Biosciences, INC Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
NASDAQ
Renaissance Technologies LLC and Renaissance Technologies Holdings Corporation have reported beneficial ownership of 6.00% of Xenetic Biosciences, Inc. common stock as of March 31, 2026.
NASDAQ
Renaissance Technologies LLC and its parent company have disclosed a 7.79% beneficial ownership stake in Xenetic Biosciences, Inc. as of an event date in late 2025.